Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.
about
Incretin-Based Therapy for Prevention of Diabetic Vascular ComplicationsCarotenoids from Marine Microalgae: A Valuable Natural Source for the Prevention of Chronic DiseasesInflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targetsRole of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A ReviewMolecular mechanisms of diabetic vascular complicationsSuperoxide production by mitochondria of insulin-sensitive tissues: mechanistic differences and effect of early diabetes.Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.Pathological aspects of lipid peroxidation.High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity.PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damageIsoprostane generation and function.Oxidative stress in diabetes.High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosisShould antioxidant status be considered in interventional trials with antioxidants?Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.Pathological significance of mitochondrial glycationAldose reductase-catalyzed reduction of aldehyde phospholipidsClinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review.Urinary Phthalate Metabolites and Biomarkers of Oxidative Stress in a Mexican-American Cohort: Variability in Early and Late Pregnancy.Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.Markers of Oxidative Stress during Diabetes Mellitus.Glycated human albumin alters mitochondrial respiration in preadipocyte 3T3-L1 cells.Influence of estrogen-related receptor γ (ESRRG) rs1890552 A > G polymorphism on changes in fasting glucose and arterial stiffness.Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1The thrombotic events in polycythemia vera patients may be related to increased oxidative stress.Relationship among superoxide-related enzyme, PPARs, and endothelium-dependent relaxation in murine aortas previously organ-cultured in high-glucose conditions.Breath markers and soluble lipid peroxidation markers in critically ill patients.An aldose reductase with 20 alpha-hydroxysteroid dehydrogenase activity is most likely the enzyme responsible for the production of prostaglandin f2 alpha in the bovine endometrium.Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus.PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes.8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells.Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8-epi-PGF(2alpha).Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes.Diabetes Mellitus induces alterations in metallothionein protein expression and metal levels in the testis and liver.Attenuation of oxidative stress in Type 1 diabetic rats supplemented with a seasoning obtained from winemaking by-products and its effect on endothelial function.Fruit and vegetable intake and the association with glucose parameters: a cross-sectional analysis of the Let's Prevent Diabetes Study.
P2860
Q26765470-92A5CE56-721E-42DE-B5D6-84AC1DA84AFBQ26796627-29CCBA2D-BF3A-4E61-A46B-2DDE95837A8FQ26866480-E47500E2-6440-4449-A0BC-5D7A5AABC066Q28072656-561831CC-D528-4B48-90B2-5CCBD3B3DF42Q33558421-923FEFD0-C84A-47EF-AAC6-88B3C0E245ACQ33618562-289CAEBA-A6A1-4A8C-82AC-F6701F18501DQ33668501-2ED98BA9-FE0A-48DB-8974-8F30D699984EQ33922502-C7E3AED8-01C0-4C8E-9FE8-4A7035ABDBBEQ34137628-54AA06FA-D572-4F38-B082-957C9A827BD3Q34493756-DB83079E-C20E-457A-9953-D51BE4107A0FQ34851871-4CA76922-2783-4248-90C3-9FE6CD8FBFF4Q35070159-6C4646E8-AEB4-4B57-9DE9-1D62BD2E695DQ35332267-3ED94BE6-91AF-4110-85FC-07AEB0A10FCFQ35576066-6287519D-AFA5-45EF-A81B-F7B5C81ECBDBQ35581270-BD94F8D2-985B-404D-8407-9A962B748CFCQ35582426-3752E659-4649-4B9A-A133-41048651297EQ35597601-94915A89-7723-45B5-8628-5529F13DC016Q36072507-9832CDDA-E33A-4B1E-86CB-0E916AD97E8AQ36330024-E999E999-23B4-4441-88C3-DD145FBD19F4Q36359500-9F9FF7EF-11ED-420D-9160-B30BD3361EE6Q36677933-BD8E47C3-A3A0-4BA6-A961-2FA295CD5EF0Q37246788-0CC198D8-A054-40B4-8F95-433F213D0376Q37518424-E3418E0E-C50D-4439-8C7D-91BDD953EC82Q37588694-6DF37C56-62B1-49C8-A651-E3EDE92F8CA6Q38575779-84C4396D-AB6B-4A31-B967-1F784C6E1948Q38764376-50BD0FF7-4E4D-4AD0-9C95-8107891CBDC1Q41548263-4EA8D3DF-0667-4CA4-A9EB-B045B12EEA55Q42535721-5894AC55-A27C-4A5C-BD44-6FEBF46CE3D3Q42759431-DB975577-23C8-4936-899C-B6F1F6377F4BQ42961710-4CDE6E9E-7333-4294-9E92-7531630FDB75Q44125563-422C908A-E438-46AE-BFA8-AC2AD327F736Q44292894-C3A1DE8D-FC73-40AC-B698-8C2C0E3F0153Q44477014-9D66FE30-C060-4149-A482-C5D175875814Q44612931-3ABFA152-64F8-4F75-A6E5-259B70CE80EAQ44980046-1FFCE80D-DCBF-4CFC-9BAB-0586CDE8E814Q45257970-1AA72218-AC52-42D2-AA39-8DF5C8EF0391Q46875973-1BB71867-8BD1-4F3D-90A5-4C7149072996Q48008234-D9A1F098-0515-4CB8-8777-DA6DEAAB091CQ48311036-D7BB8926-4877-4F68-9897-DEE1099BB8F0Q51346564-11B7BFF8-F6D9-45FE-8314-4347E0DEC6FB
P2860
Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Oxidative stress and cardiovas ...... ew markers on an old paradigm.
@ast
Oxidative stress and cardiovas ...... ew markers on an old paradigm.
@en
Oxidative stress and cardiovas ...... ew markers on an old paradigm.
@nl
type
label
Oxidative stress and cardiovas ...... ew markers on an old paradigm.
@ast
Oxidative stress and cardiovas ...... ew markers on an old paradigm.
@en
Oxidative stress and cardiovas ...... ew markers on an old paradigm.
@nl
prefLabel
Oxidative stress and cardiovas ...... ew markers on an old paradigm.
@ast
Oxidative stress and cardiovas ...... ew markers on an old paradigm.
@en
Oxidative stress and cardiovas ...... ew markers on an old paradigm.
@nl
P1476
Oxidative stress and cardiovas ...... new markers on an old paradigm
@en
P2093
A Mezzetti
F Cuccurullo
P304
P356
10.1016/S0008-6363(00)00118-8
P577
2000-08-01T00:00:00Z